Studies of direct intratumoral gene transfer using cationic lipid- complexed plasmid DNA

Paul R. Clark, Alison T Stopeck, Marilyn Ferrari, Suezanne E. Parker, Evan M Hersh

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Cationic lipid-mediated gene transfer is a safe and effective means of delivering potent immunomodulatory cytokines directly into tumors. This approach avoids undesirable side effects, including systemic toxicities. To investigate key factors affecting intratumoral (i.t.) gene transfer, cationic lipid-DNA complexes were injected into subcutaneous human melanoma tumors in severe combined immunodeficient mice. Animals received i.t. injections of VR1103, a DNA plasmid encoding the gene for human interleukin-2 (IL-2), either alone or complexed with the cationic lipid N-(1 -(2,3- dimyristyloxypropyl)-N,N-dimethyl-(2-hydroxyethyl) ammonium bromide/dioleoyl phosphatidylethanolamine (DMRIE/DOPE). Tumors were subcultured and supernatants were tested for IL-2 secretion by enzyme-linked immunosorbent assay. IL-2 secretion was consistently higher when lipid:DNA (L:D) complexes were formulated at high L:D ratios (wt/wt), and IL-2 transgene expression increased in a DNA dose-dependent manner. A comparison of naked plasmid and lipid-complexed DNA revealed that lipid complexes were more effective for i.t. gene transfer. Using an enhanced green fluorescent protein reporter plasmid and flow cytometry, i.t. transfection efficiency was 1.74% (± 1.08%). Tumor injection technique, including injection volume and location, had a limited impact on i.t. gene transfer. These results indicate that the formulation and dosage of cationic L:D complexes, but not injection technique, play a key role in determining the level of i.t. transgene expression.

Original languageEnglish (US)
Pages (from-to)853-860
Number of pages8
JournalCancer Gene Therapy
Volume7
Issue number6
StatePublished - 2000

Fingerprint

Plasmids
Lipids
DNA
Genes
Interleukin-2
Injections
Transgenes
Neoplasms
SCID Mice
Transfection
Melanoma
Flow Cytometry
Enzyme-Linked Immunosorbent Assay
Cytokines

Keywords

  • Cationic lipids
  • Interleukin-2
  • Intratumoral
  • Plasmid DNA
  • Severe combined immunodeficient

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Studies of direct intratumoral gene transfer using cationic lipid- complexed plasmid DNA. / Clark, Paul R.; Stopeck, Alison T; Ferrari, Marilyn; Parker, Suezanne E.; Hersh, Evan M.

In: Cancer Gene Therapy, Vol. 7, No. 6, 2000, p. 853-860.

Research output: Contribution to journalArticle

Clark, Paul R. ; Stopeck, Alison T ; Ferrari, Marilyn ; Parker, Suezanne E. ; Hersh, Evan M. / Studies of direct intratumoral gene transfer using cationic lipid- complexed plasmid DNA. In: Cancer Gene Therapy. 2000 ; Vol. 7, No. 6. pp. 853-860.
@article{3aeaf8fe6ef84dcaa5949cc728bc6bf4,
title = "Studies of direct intratumoral gene transfer using cationic lipid- complexed plasmid DNA",
abstract = "Cationic lipid-mediated gene transfer is a safe and effective means of delivering potent immunomodulatory cytokines directly into tumors. This approach avoids undesirable side effects, including systemic toxicities. To investigate key factors affecting intratumoral (i.t.) gene transfer, cationic lipid-DNA complexes were injected into subcutaneous human melanoma tumors in severe combined immunodeficient mice. Animals received i.t. injections of VR1103, a DNA plasmid encoding the gene for human interleukin-2 (IL-2), either alone or complexed with the cationic lipid N-(1 -(2,3- dimyristyloxypropyl)-N,N-dimethyl-(2-hydroxyethyl) ammonium bromide/dioleoyl phosphatidylethanolamine (DMRIE/DOPE). Tumors were subcultured and supernatants were tested for IL-2 secretion by enzyme-linked immunosorbent assay. IL-2 secretion was consistently higher when lipid:DNA (L:D) complexes were formulated at high L:D ratios (wt/wt), and IL-2 transgene expression increased in a DNA dose-dependent manner. A comparison of naked plasmid and lipid-complexed DNA revealed that lipid complexes were more effective for i.t. gene transfer. Using an enhanced green fluorescent protein reporter plasmid and flow cytometry, i.t. transfection efficiency was 1.74{\%} (± 1.08{\%}). Tumor injection technique, including injection volume and location, had a limited impact on i.t. gene transfer. These results indicate that the formulation and dosage of cationic L:D complexes, but not injection technique, play a key role in determining the level of i.t. transgene expression.",
keywords = "Cationic lipids, Interleukin-2, Intratumoral, Plasmid DNA, Severe combined immunodeficient",
author = "Clark, {Paul R.} and Stopeck, {Alison T} and Marilyn Ferrari and Parker, {Suezanne E.} and Hersh, {Evan M}",
year = "2000",
language = "English (US)",
volume = "7",
pages = "853--860",
journal = "Cancer Gene Therapy",
issn = "0929-1903",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Studies of direct intratumoral gene transfer using cationic lipid- complexed plasmid DNA

AU - Clark, Paul R.

AU - Stopeck, Alison T

AU - Ferrari, Marilyn

AU - Parker, Suezanne E.

AU - Hersh, Evan M

PY - 2000

Y1 - 2000

N2 - Cationic lipid-mediated gene transfer is a safe and effective means of delivering potent immunomodulatory cytokines directly into tumors. This approach avoids undesirable side effects, including systemic toxicities. To investigate key factors affecting intratumoral (i.t.) gene transfer, cationic lipid-DNA complexes were injected into subcutaneous human melanoma tumors in severe combined immunodeficient mice. Animals received i.t. injections of VR1103, a DNA plasmid encoding the gene for human interleukin-2 (IL-2), either alone or complexed with the cationic lipid N-(1 -(2,3- dimyristyloxypropyl)-N,N-dimethyl-(2-hydroxyethyl) ammonium bromide/dioleoyl phosphatidylethanolamine (DMRIE/DOPE). Tumors were subcultured and supernatants were tested for IL-2 secretion by enzyme-linked immunosorbent assay. IL-2 secretion was consistently higher when lipid:DNA (L:D) complexes were formulated at high L:D ratios (wt/wt), and IL-2 transgene expression increased in a DNA dose-dependent manner. A comparison of naked plasmid and lipid-complexed DNA revealed that lipid complexes were more effective for i.t. gene transfer. Using an enhanced green fluorescent protein reporter plasmid and flow cytometry, i.t. transfection efficiency was 1.74% (± 1.08%). Tumor injection technique, including injection volume and location, had a limited impact on i.t. gene transfer. These results indicate that the formulation and dosage of cationic L:D complexes, but not injection technique, play a key role in determining the level of i.t. transgene expression.

AB - Cationic lipid-mediated gene transfer is a safe and effective means of delivering potent immunomodulatory cytokines directly into tumors. This approach avoids undesirable side effects, including systemic toxicities. To investigate key factors affecting intratumoral (i.t.) gene transfer, cationic lipid-DNA complexes were injected into subcutaneous human melanoma tumors in severe combined immunodeficient mice. Animals received i.t. injections of VR1103, a DNA plasmid encoding the gene for human interleukin-2 (IL-2), either alone or complexed with the cationic lipid N-(1 -(2,3- dimyristyloxypropyl)-N,N-dimethyl-(2-hydroxyethyl) ammonium bromide/dioleoyl phosphatidylethanolamine (DMRIE/DOPE). Tumors were subcultured and supernatants were tested for IL-2 secretion by enzyme-linked immunosorbent assay. IL-2 secretion was consistently higher when lipid:DNA (L:D) complexes were formulated at high L:D ratios (wt/wt), and IL-2 transgene expression increased in a DNA dose-dependent manner. A comparison of naked plasmid and lipid-complexed DNA revealed that lipid complexes were more effective for i.t. gene transfer. Using an enhanced green fluorescent protein reporter plasmid and flow cytometry, i.t. transfection efficiency was 1.74% (± 1.08%). Tumor injection technique, including injection volume and location, had a limited impact on i.t. gene transfer. These results indicate that the formulation and dosage of cationic L:D complexes, but not injection technique, play a key role in determining the level of i.t. transgene expression.

KW - Cationic lipids

KW - Interleukin-2

KW - Intratumoral

KW - Plasmid DNA

KW - Severe combined immunodeficient

UR - http://www.scopus.com/inward/record.url?scp=0033916297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033916297&partnerID=8YFLogxK

M3 - Article

C2 - 10880015

AN - SCOPUS:0033916297

VL - 7

SP - 853

EP - 860

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

SN - 0929-1903

IS - 6

ER -